(Q36262281)

13 August 2017

1 reference

title

Dendritic cell dysfunction in cancer: a mechanism for immunosuppression (English)

1 reference

13 August 2017

1 reference

1 reference

Alberto Pinzon-Charry

series ordinal

1

1 reference

13 August 2017

Tammy Maxwell

series ordinal

2

1 reference

13 August 2017

J Alejandro López

series ordinal

3

1 reference

13 August 2017

publication date

1 October 2005

1 reference

Immunology & Cell Biology

13 August 2017

published in

1 reference

13 August 2017

volume

83

1 reference

13 August 2017

issue

5

1 reference

13 August 2017

page(s)

451-461

1 reference

Immunologic mechanisms of antitumor activity

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Inhibition of tumor growth by elimination of granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Surgical and physical stress increases circulating blood dendritic cell counts independently of monocyte counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Immunobiology of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Spontaneous regression of neoplasms: new possibilities for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

S-100 protein-positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Altered maturation of peripheral blood dendritic cells in patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Gangliosides from human melanoma tumors impair dendritic cell differentiation from monocytes and induce their apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Expression of interleukin 10 in human melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Predictors of clinical response to interleukin-2--based immunotherapy in melanoma patients: a French multiinstitutional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

In vivo cytokine production and recombinant interleukin 2 immunotherapy: an insight into the possible mechanisms underlying clinical responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Ex vivo induction of multiple myeloma–specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

GM-CSF-secreting melanoma vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Clinical significance of the determination of angiogenic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Vascular endothelial growth factor inhibits maturation of dendritic cells induced by lipopolysaccharide, but not by proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Role of tumor-associated gangliosides in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Structure, organization, and function of glycosphingolipids in membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Tumor-derived MUC1 mucins interact with differentiating monocytes and induce IL-10highIL-12low regulatory dendritic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Transduction of dendritic cells with Bcl-xL increases their resistance to prostate cancer-induced apoptosis and antitumor effect in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-alpha, but strongly enhanced by interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Interleukin-10 in viral diseases and cancer: exiting the labyrinth?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Nitric oxide (NO): an effector of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Nitric oxide synthase activity in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Nitric oxide confers therapeutic activity to dendritic cells in a mouse model of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Ceramide mediates tumor-induced dendritic cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Mouse and human dendritic cell subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Dendritic cells pulsed with intact Streptococcus pneumoniae elicit both protein- and polysaccharide-specific immunoglobulin isotype responses in vivo through distinct mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Coexpression of CD40 and CD40L on B lymphoma and carcinoma cells: an autocrine anti-apoptotic role

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

A push-pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01371.X

10.1111/J.1440-1711.2005.01371.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference